[HTML][HTML] Model-informed precision dosing: State of the art and future perspectives

IK Minichmayr, E Dreesen, M Centanni, Z Wang… - Advanced drug delivery …, 2024 - Elsevier
Abstract Model-informed precision dosing (MIPD) stands as a significant development in
personalized medicine to tailor drug dosing to individual patient characteristics. MIPD moves …

Pharmacokinetics, pharmacodynamics and pharmacogenetics of tacrolimus in kidney transplantation

M Yu, M Liu, W Zhang, Y Ming - Current drug metabolism, 2018 - ingentaconnect.com
Background: Tacrolimus (Tac, or FK506), a calcineurin inhibitor (CNI), is the first-line
immunosuppressant which consists of the footstone as immunosuppressive regimens in …

The role of pharmacogenetics in the disposition of and response to tacrolimus in solid organ transplantation

DA Hesselink, R Bouamar, L Elens… - Clinical …, 2014 - Springer
The calcineurin inhibitor tacrolimus is the backbone of immunosuppressive drug therapy
after solid organ transplantation. Tacrolimus is effective in preventing acute rejection but has …

Tacrolimus exposure prediction using machine learning

JB Woillard, M Labriffe, J Debord… - Clinical Pharmacology …, 2021 - Wiley Online Library
The aim of this work is to estimate the area‐under the blood concentration curve of
tacrolimus (TAC) following bid or qd dosing in organ transplant patients, using Xgboost …

Individualizing liver transplant immunosuppression using a phenotypic personalized medicine platform

A Zarrinpar, DK Lee, A Silva, N Datta, T Kee… - Science translational …, 2016 - science.org
Posttransplant immunosuppressive drugs such as tacrolimus have narrow therapeutic
ranges. Inter-and intraindividual variability in dosing requirements conventionally use …

Pharmacogenetic aspects of the use of tacrolimus in renal transplantation: recent developments and ethnic considerations

JT Tang, LM Andrews, T van Gelder… - Expert opinion on …, 2016 - Taylor & Francis
ABSTRACT Introduction: Tacrolimus (Tac) is effective in preventing acute rejection but has
considerable toxicity and inter-individual variability in pharmacokinetics and …

Importance of hematocrit for a tacrolimus target concentration strategy

E Størset, N Holford, K Midtvedt, S Bremer… - European journal of …, 2014 - Springer
Purpose To identify patient characteristics that influence tacrolimus individual dose
requirement in kidney transplant recipients. Methods Data on forty-four 12-h …

Estimation of drug exposure by machine learning based on simulations from published pharmacokinetic models: the example of tacrolimus

JB Woillard, M Labriffe, A Prémaud, P Marquet - Pharmacological research, 2021 - Elsevier
We previously demonstrated that Machine learning (ML) algorithms can accurately estimate
drug area under the curve (AUC) of tacrolimus or mycophenolate mofetil (MMF) based on …

Fundamentals of population pharmacokinetic modelling: validation methods

CMT Sherwin, TKL Kiang, MG Spigarelli… - Clinical …, 2012 - Springer
Population pharmacokinetic modelling is widely used within the field of clinical
pharmacology as it helps to define the sources and correlates of pharmacokinetic variability …

Population pharmacokinetic models of tacrolimus in adult transplant recipients: a systematic review

R Kirubakaran, SL Stocker, S Hennig, RO Day… - Clinical …, 2020 - Springer
Abstract Background and Objectives Numerous population pharmacokinetic (PK) models of
tacrolimus in adult transplant recipients have been published to characterize tacrolimus PK …